337 related articles for article (PubMed ID: 25701988)
61. Medical Neglect by Underprescription and Underutilization of Hydroxyurea in Children with Sickle Cell Disease.
Rana S
South Med J; 2016 Sep; 109(9):503-5. PubMed ID: 27598349
[No Abstract] [Full Text] [Related]
62. Sickle cell paths converge on hydroxyurea.
Platt OS
Nat Med; 1995 Apr; 1(4):307-8. PubMed ID: 7585059
[No Abstract] [Full Text] [Related]
63. Hydroxyurea Improves Oxygen Saturation in Children With Sickle Cell Disease.
Pashankar FD; Manwani D; Lee MT; Green NS
J Pediatr Hematol Oncol; 2015 Apr; 37(3):242-3. PubMed ID: 25222060
[No Abstract] [Full Text] [Related]
64. Hydroxyurea and stroke prevention in sickle cell anaemia: the challenge of application in sub-Saharan Africa.
Diop S; de Montalembert M
Lancet Haematol; 2023 Apr; 10(4):e237-e238. PubMed ID: 36870359
[No Abstract] [Full Text] [Related]
65. When should hydroxyurea be used for children with sickle cell disease?
Mueller BU
Pediatrics; 2008 Dec; 122(6):1365-6. PubMed ID: 19047256
[No Abstract] [Full Text] [Related]
66. Sickle cell anaemia: current therapies.
Vermylen C
Transfus Apher Sci; 2013 Oct; 49(2):151-4. PubMed ID: 23954416
[TBL] [Abstract][Full Text] [Related]
67. Long-term hydroxyurea treatment in young sickle cell patients.
Maier-Redelsperger M; Labie D; Elion J
Curr Opin Hematol; 1999 Mar; 6(2):115-20. PubMed ID: 10088642
[TBL] [Abstract][Full Text] [Related]
68. Experts urge wider use of hydroxyurea for sickle cell disease.
Traynor K
Am J Health Syst Pharm; 2008 Apr; 65(7):592-3. PubMed ID: 18359960
[No Abstract] [Full Text] [Related]
69. Reduction of the clinical severity of sickle cell/beta-thalassemia with hydroxyurea: the experience of a single center in Greece.
Loukopoulos D; Voskaridou E; Kalotychou V; Schina M; Loutradi A; Theodoropoulos I
Blood Cells Mol Dis; 2000 Oct; 26(5):453-66. PubMed ID: 11112383
[TBL] [Abstract][Full Text] [Related]
70. New option for primary stroke prevention in sickle cell anaemia.
DeBaun MR; Kirkham FJ
Lancet; 2016 Feb; 387(10019):626-627. PubMed ID: 26670618
[No Abstract] [Full Text] [Related]
71. Approximately 40 000 children with sickle cell anemia require screening with TCD and treating with hydroxyurea for stroke prevention in three states in northern Nigeria.
Galadanci AA; Galadanci NA; Jibir BW; Abdullahi SU; Idris N; Gambo S; Ali Abubakar SA; Kabo NA; Bello-Manga H; Haliru L; Bashir I; Aliyu MH; Galadanci JA; DeBaun MR
Am J Hematol; 2019 Nov; 94(11):E305-E307. PubMed ID: 31423630
[No Abstract] [Full Text] [Related]
72. Hydroxyurea, sickle cell disease and renal transplantation.
Allen A; Scoble J; Snowden S; Hambley H; Bellingham A
Nephron; 1997; 75(1):106-7. PubMed ID: 9031282
[No Abstract] [Full Text] [Related]
73. DNA damage in blood leukocytes of individuals with sickle cell disease treated with hydroxyurea.
Friedrisch JR; Prá D; Maluf SW; Bittar CM; Mergener M; Pollo T; Kayser M; da Silva MA; Henriques JA; da Rocha Silla LM
Mutat Res; 2008 Jan; 649(1-2):213-20. PubMed ID: 17988936
[TBL] [Abstract][Full Text] [Related]
74. Opportunities for model-based precision dosing in the treatment of sickle cell anemia.
Dong M; Mizuno T; Vinks AA
Blood Cells Mol Dis; 2017 Sep; 67():143-147. PubMed ID: 28807656
[TBL] [Abstract][Full Text] [Related]
75. Hydroxyurea treatment decreases glomerular hyperfiltration in children with sickle cell anemia.
Aygun B; Mortier NA; Smeltzer MP; Shulkin BL; Hankins JS; Ware RE
Am J Hematol; 2013 Feb; 88(2):116-9. PubMed ID: 23255310
[TBL] [Abstract][Full Text] [Related]
76. Resolution of chronic hypoxemia in pediatric sickle cell patients after treatment with hydroxyurea.
Singh SA; Koumbourlis AC; Aygun B
Pediatr Blood Cancer; 2008 Jun; 50(6):1258-60. PubMed ID: 18293380
[TBL] [Abstract][Full Text] [Related]
77. European register of patients with sickle cell disease treated with hydroxyurea is being set up.
Davies SC; Roberts-Harwood M
BMJ; 1998 Aug; 317(7157):541-2. PubMed ID: 9712619
[No Abstract] [Full Text] [Related]
78. Intensive hydroxyurea dosing in very young children with sickle cell anemia.
Wang WC; Brown RC; McNaull MA; Rogers ZR; Barton M; Dua MR; Hankins JS; Gossett J; Richardson J; Porter JS; Kang G; Estepp JH
Blood Adv; 2023 Nov; 7(22):6931-6935. PubMed ID: 37695741
[No Abstract] [Full Text] [Related]
79. Proportion of adults with sickle cell anemia and pain crises receiving hydroxyurea.
Stettler N; McKiernan CM; Melin CQ; Adejoro OO; Walczak NB
JAMA; 2015 Apr; 313(16):1671-2. PubMed ID: 25919532
[No Abstract] [Full Text] [Related]
80. Effect of Hydroxyurea Therapy on Pulmonary Function in Children with Sickle Cell Anemia.
McLaren A; Klingel M; Behera S; Odame I; Kirby-Allen M; Grasemann H
Am J Respir Crit Care Med; 2017 Mar; 195(5):689-691. PubMed ID: 28248149
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
